Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

unknown1
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown133%
not_yet_recruiting133%
enrolling_by_invitation133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruiting

Prognostic Model for MASLD Related Cirrhosis

NCT07082751
enrolling_by_invitationnot_applicable

Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation.

NCT06277505
unknownnot_applicable

Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients

NCT02956655

Clinical Trials (3)

Showing 3 of 3 trials
NCT07082751

Prognostic Model for MASLD Related Cirrhosis

Not Yet Recruiting
NCT06277505Not Applicable

Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation.

Enrolling By Invitation
NCT02956655Not Applicable

Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3